|
|
| MRD / Regn No. |
: 20170001492 |
Date |
: 15/07/2026 |
| Patient Name |
: Arnab Das |
Age & Gender |
: 45 Yrs. / Male |
| Contact No. |
: 7093883912 |
UHID |
: |
| Ht / Wt / BMI |
: 175 / 84 / 27.43 |
BP S / BP D |
: / |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
HYPOTHYROIDISM, UNSPECIFIED (02/Dec/2017) | NAFLD (04/Jul/2020) | TYPE 2 DM (01/Jan/2016) | HYPOTHYROIDISM (12/May/2014) | |
|
Subjective |
: |
IS TAKING MEDICATIONS REGULARLY,TOLERATING SEMAGLUTIDE
|
|
Objective |
: |
NONE |
|
Analysis |
: |
NAFLD,T2DM,DYSLIPIDEMIA,HYPOTHYROIDISM,OBESITY,CDR > 0.2 |
|
Plan |
: |
HOLD MF AND SGLT2I,SEE ME IN 2 MONTHS WITH TESTING,INCREASE SEMAGLUTIDE 1.7 MG INJECTABLE |
|
| Salient Investigations |
: |
CALCIUM: 9.3 mg/DL | CREATININE: 1.06 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 80.48 mL/min/1.73m2 | TSH : 1.3 mIU/L | UREA: 19 mg/dL | URIC ACID: 3.8 | FASTING PLASMA GLUCOSE (FPG): 94 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.1 % | POST PRANDIAL GLUCOSE (2HPP): 98 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 41 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 68 mg/dL | TGL TRIGLYCERIDE: 88 mg/dL | TOTAL CHOLESTEROL: 127 mg/dl | ALBUMIN (SERUM): 4.1 g/dL | ALKALINE PHOSPHOTASE: 97 IU/L | DIRECT BILIRUBIN: 0.1 mg/dl | SGOT (AST): 27 U/L | SGPT (ALT): 44 IU/L | TOTAL BILIRUBIN: 0.4 mg/dL | HEMOGLOBIN: 15 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 86.6 fL | PLATELETS: 161 thou cells/ ul | FIB4: 1.14 | WBC WHITE BLOOD CELLS: 860 K/uL | POTASSIUM: 4.4 meQ/L | SODIUM: 137 meq/L |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
THYROXINE 112 MCG
THYRONORM 112 MCG
Medicine For LOW THYROID |
PO |
1-0-0 |
EMPTY STOMACH
|
TILL NEXT VISIT |
| MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR B... | |
|
2 |
ROSUVASTATIN 10 MG
CRESTOR 10 MG
Medicine For CHOELSTEROL |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY | |
|
3 |
INJECTION SEMAGLUTIDE 1.7 MG
SEMBOLIC 1.7 MG
Medicine For DIABETES OBESITY |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA VOMITING AND VISION DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 14/Sep/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP HBA1C |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription |
Powered By:  |